Analytical methods for research peptides

Identity and purity are two different questions

These are the two questions every analytical certificate answers, and they are answered by different instruments because they are not the same question.

Identity

Is this molecule the one it is labelled as? Answered by mass spectrometry, which measures molecular mass directly.

Purity

What proportion of the material is that molecule, rather than something else? Answered by chromatography, which separates a mixture into its components and measures their relative sizes.

A material can be extremely pure and still be the wrong compound. It can also be unambiguously the right compound and be half of what is in the vial. Neither figure substitutes for the other, and a certificate that reports only one of them has told you half of what you need.

Purity by reverse-phase HPLC

High-performance liquid chromatography pushes a dissolved sample through a packed column under pressure. Components travel at different speeds depending on how strongly they interact with the column packing, so a mixture that entered as one band leaves as a series of separated bands. A detector at the far end records each one as it emerges.

Reverse-phase is the common configuration for peptides: a non-polar stationary phase, a polar mobile phase, and a gradient that becomes progressively less polar over the run so that increasingly hydrophobic components are released in turn. Detection is typically ultraviolet absorbance in the region where the peptide bond itself absorbs.

What "98.6%" actually means

Almost always it means area percent: the area under the main peak, divided by the total area under every integrated peak in the run, expressed as a percentage. It is a statement about proportion within what the method detected.

That last clause is the whole caveat. Area percent assumes every component responds to the detector in proportion to how much of it is present. Components that absorb weakly at the detection wavelength are under-represented. Components that do not absorb at all — many salts, residual solvents, water — are not in the denominator, because the detector never saw them. A peptide reported at 98.6% by RP-HPLC can still be a minority of the vial by mass.

This is why net peptide content, water content and counter-ion content are separate determinations, and why a purity figure alone does not tell you how much peptide is in a vial.

Identity by mass spectrometry

Mass spectrometry ionises the sample, accelerates the ions through a field, and measures their mass-to-charge ratio. For a peptide of known sequence the theoretical mass is a calculation, so the measurement is a direct comparison: the observed mass either matches the expected mass within the method's tolerance, or it does not.

Electrospray ionisation typically produces a series of multiply-charged ions rather than one peak, and the neutral mass is reconstructed from that series. This is normal, and a spectrum showing a charge-state envelope is not a defect.

LC-MS: the two run together

Coupling liquid chromatography to a mass spectrometer separates the sample first and identifies each separated component second. That answers a question neither instrument answers alone: not just how large the impurity peaks are, but what they are. A truncated sequence, a deletion, an oxidised residue and a completely unrelated contaminant are all "an impurity peak" to an ultraviolet detector, and are distinguishable by mass.

What mass spectrometry cannot settle

Mass is not sequence. Two peptides containing the same residues in a different order have the same mass, and isomeric substitutions can be invisible to a mass measurement alone. Establishing sequence requires fragmentation — tandem mass spectrometry — or an orthogonal method such as Edman degradation. A certificate reporting "identity confirmed by MS" is reporting a mass match, and a mass match is strong evidence, not proof of sequence.

Reading a chromatogram

A chromatogram plots detector response against time. Time runs left to right; height is how much signal the detector saw at that moment. Each peak is a component leaving the column.

Retention time

Where along the x-axis a peak appears. It is characteristic of a component under one specific method, and it is not transferable between methods, columns or instruments.

Peak area

The integrated area beneath a peak. This, not peak height, is what a purity percentage is calculated from.

Baseline

The signal with nothing eluting. A real baseline has visible noise and often drifts during a gradient. A perfectly flat one has usually been processed.

Resolution

How completely two adjacent peaks separate. Peaks that do not return to baseline between them cannot be integrated independently with confidence.

What to look at first

• Whether the axes are labelled at all, and whether the run length and detection wavelength are stated.
• Whether the trace is the full run or a window cropped around the main peak. A crop can remove late-eluting impurities from view without removing them from the vial.
• Whether the main peak returns cleanly to baseline, or has a shoulder — a shoulder is a co-eluting component that area percent may be counting as product.
• Whether the integration table accompanies the trace. A percentage without the peak list behind it cannot be checked.
• Whether the lot code on the trace matches the lot code on the certificate and the vial.

Where each method stops

Stated plainly, because a testing programme that only publishes what its methods can show is more useful than one that implies they show everything.

RP-HPLC area percent

Cannot see what does not absorb at the detection wavelength. Cannot distinguish two components that co-elute. Cannot report mass content. Its percentage is relative to detected material, not to the contents of the vial.

Mass spectrometry

Cannot establish sequence order from mass alone. Cannot reliably quantify without a matched standard, because different molecules ionise with different efficiency.

Any single lot test

Describes the material at the moment it was sampled. It says nothing about how the material was handled afterwards, which is why storage conditions and the chain between test and delivery matter as much as the figure.

A certificate on its own

Establishes nothing unless the lot code on it matches the vial in front of you, and unless the laboratory that issued it is identifiable and independent.

How a lot is released

A lot moves through a fixed sequence of states, and a state is only advanced by a person. Nothing promotes itself, and a lot that fails a check does not proceed to the next one.

1. Material received and sampled against its identifying documentation.
2. Identity determined. An identity failure ends the lot — it is not a measurement to be repeated, because the material is not what it was labelled as.
3. Purity determined, with the full chromatogram retained as issued.
4. Results reviewed against the release criteria, including any out-of-specification investigation.
5. Record published at its permanent address, carrying every figure and the document behind each one.

Out-of-specification results

There are two honest outcomes. Either an assignable laboratory error is documented and the assay is repeated, with both the original and the repeat retained in the record — or there is no assignable error, the result stands, and the lot is not released. Repeating an assay until it produces an acceptable number is the practice this policy exists to prevent.

Permanence

A published lot record is permanent and is never deleted. A withdrawn lot keeps its page and states that it was withdrawn. Corrections are appended as amendments, never written over the original. A supplier who can delete the record of a bad lot has not published evidence; they have published marketing.

Why independence is the load-bearing part

A supplier testing its own material and reporting its own result is asking the buyer to trust the supplier twice. Third-party testing replaces one of those with a laboratory that has no interest in the outcome, and it only means anything if the laboratory is named — an unnamed "independent lab" is an unverifiable assertion.

A supplier-issued certificate is not worthless. It is simply a different class of evidence, and it should be labelled as what it is rather than presented as independent testing.

References

This page describes standard analytical practice. The primary references for the methods it covers:

• United States Pharmacopeia, General Chapter <621> Chromatography — system suitability, integration and reporting.
• United States Pharmacopeia, General Chapter <1225> Validation of Compendial Procedures.
• ICH Q2(R2), Validation of Analytical Procedures — specificity, accuracy, precision and the limits of quantitation.
• ICH Q6B, Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products.

Where NuePharma's own acceptance criteria and method parameters are set, they are published on the lot record they applied to, alongside the result they produced.